Bokf, Na Neurocrine Biosciences Inc Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bokf, Na holds 4,019 shares of NBIX stock, worth $504,987. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,019

Previous 4,008 0.27%

Holding current value

$504,987

Previous $551,000 16.15%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $1,260 - $1,684	11 Added 0.27%	4,019 $462,000
Q2 2024 Aug 07, 2024	SELL	$130.86 - $143.19 $3,009 - $3,293	-23 Reduced 0.57%	4,008 $551,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $3,260 - $3,593	25 Added 0.62%	4,031 $555,000
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $2,863 - $3,584	27 Added 0.68%	4,006 $527,000
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $43,155 - $53,748	-459 Reduced 10.34%	3,979 $447,000
Q2 2023 Aug 21, 2023	SELL	$89.53 - $104.87 $22,561 - $26,427	-252 Reduced 5.37%	4,438 $418,000
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $34,538 - $45,148	-367 Reduced 7.26%	4,690 $474,000
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $28,174 - $33,543	264 Added 5.51%	5,057 $604,000
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $6,994 - $8,193	-76 Reduced 1.56%	4,793 $509,000
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $5,381 - $7,104	71 Added 1.48%	4,869 $475,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $11,374 - $14,885	157 Added 3.38%	4,798 $450,000
Q4 2021 Mar 11, 2022	SELL	$79.65 - $106.22 $67,782 - $90,393	-851 Reduced 15.5%	4,641 $395,000
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $1.27 Million - $1.46 Million	-14,716 Reduced 72.82%	5,492 $527,000
Q1 2021 Apr 21, 2021	BUY	$87.57 - $119.4 $115,767 - $157,846	1,322 Added 7.0%	20,208 $1.97 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $90,473 - $112,771	-1,041 Reduced 5.22%	18,886 $1.81 Million
Q3 2020 Oct 30, 2020	BUY	$96.16 - $135.15 $94,044 - $132,176	978 Added 5.16%	19,927 $1.92 Million
Q2 2020 Aug 12, 2020	SELL	$85.09 - $130.36 $84,579 - $129,577	-994 Reduced 4.98%	18,949 $2.31 Million
Q1 2020 May 13, 2020	BUY	$75.11 - $113.76 $211,885 - $320,916	2,821 Added 16.48%	19,943 $1.73 Million
Q4 2019 Feb 12, 2020	SELL	$86.8 - $118.57 $55,204 - $75,410	-636 Reduced 3.58%	17,122 $1.84 Million
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $20,452 - $24,766	-244 Reduced 1.36%	17,758 $1.6 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $899,749 - $1.14 Million	12,455 Added 224.54%	18,002 $1.52 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $700,862 - $925,551	-10,112 Reduced 64.58%	5,547 $489,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $301,291 - $548,427	4,410 Added 39.2%	15,659 $1.12 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $454,946 - $579,035	4,601 Added 69.21%	11,249 $1.38 Million
Q2 2018 Aug 13, 2018	BUY	$75.3 - $105.99 $500,594 - $704,621	6,648 New	6,648 $653,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account